| Code | CSB-AP002181HU |
| Abbreviation | Recombinant Human TNFRSF13C protein, partial (Active) |
| MSDS | |
| Size | $142 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
BAFF-R (TNFRSF13C) serves as the primary receptor driving BAFF-dependent B cell survival, making it a critical target in autoimmune disease and B cell malignancy research. This tag-free recombinant construct spans the extracellular ligand-binding domain (residues 1–76) and demonstrates confirmed blocking activity, with an ED50 of 1.0–5.0 µg/ml for inhibiting BAFF-induced mouse splenocyte survival in the presence of 1.0 µg/ml recombinant human BAFF. This functional validation supports use in competitive inhibition assays, blocking antibody screening, BAFF–BAFF-R interaction studies by SPR or BLI, and small-molecule inhibitor discovery campaigns targeting the BAFF signaling axis. Expressed in *E. coli* without affinity tags, the protein provides a suitable basis for epitope mapping and ligand-binding ELISAs, with purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/µg—criteria that satisfy requirements for cell-based functional assays.
There are currently no reviews for this product.